Effect of soybean protein on novel cardiovascular disease risk factors: A randomized controlled trial

European Journal of Clinical Nutrition

Volumn 67, Issue 1, 2013, Pages 58-63

  Rebholz, C M ^a   Reynolds, K ^a,b   Wofford, M R ^c   Chen, J ^d   Kelly, T N ^a   Mei, H ^a   Whelton, P K ^a   He, J ^a,d  

^a TULANE UNIVERSITY   (United States)

^b Kaiser Permanente Southern California ^*  (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipokines; Carbohydrates; Clinical trial; Inflammation; Milk proteins; Soybean proteins

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBOHYDRATE DERIVATIVE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH MOLECULAR WEIGHT ADIPONECTIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LEPTIN; MILK PROTEIN; RESISTIN; SOYBEAN PROTEIN; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CARBOHYDRATE INTAKE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; MULTICENTER STUDY; NORMAL HUMAN; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; TURBIDIMETRY;

ADIPOKINES; ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LEPTIN; LOUISIANA; MALE; MIDDLE AGED; MILK PROTEINS; MISSISSIPPI; RISK FACTORS; SOYBEAN PROTEINS;

GLYCINE MAX;

EID: 84872153247     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2012.186     Document Type: Article

References (40)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757. (Pubitemid 43767064)
2. Writing Group Members, Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-e220.
3. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, AM Gotto et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1997; 96: 4219-4225. (Pubitemid 28007447)
4. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P et al. Low grade inflammation and coronary heart disease: prospective study and updated metaanalyses. BMJ 2000; 321: 199-204. (Pubitemid 30459555)
5. Lee SH, Ha JW, Kim JS, Choi EY, Park S, Kang SM et al. Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry. Coron Artery Dis 2009; 20: 33-39.
6. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006; 47: C7-C12.
7. Tesauro M, Canale MP, Rodia G, Di Daniele N, Lauro D, Scuteri A et al. Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. Cardiol Res Pract 2011; 2011: 653182.
8. Erdman JW. AHA science advisory: Soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition Committee of the AHA. Circulation 2000; 102: 2555-2559.
9. Reynolds K, Chin A, Lees KA, Nguyen A, Bujnowski D, He J. A meta-analysis of the effect of soy protein supplementation on serum lipids. Am J Cardiol 2006; 98: 633-640. (Pubitemid 44233460)
10. Rebholz CM, Friedman EE, Powers LJ, Arroyave WD, He J, Kelly TN. Dietary protein intake and blood pressure: a meta-analysis of randomized controlled trials. Am J Epidemiol 2012; 176: S27-S43.
11. Fanti P, Asmis R, Stephenson TJ, Sawaya BP, Franke AA. Positive effect of dietary soy in ESRD patients with systemic inflammation-correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol Dial Transplant 2006; 21: 2239-2246. (Pubitemid 44295051)
12. Charles C, Yuskavage J, Carlson O, John M, Tagalicud AS, Maggio M et al. Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause 2009; 16: 395-400.
13. Blum A, Lang N, Peleg A, Vigder F, Israeli P, Gumanovsky M et al. Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia. Am Heart J 2003; 145: e7.
14. Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS. Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women. Eur J Clin Nutr 2008; 62: 1419-1425. (Pubitemid 352807336)
15. Steinberg FM, Guthrie NL, Villablanca AC, Kumar K, Murray MJ. Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr 2003; 78: 123-130. (Pubitemid 39655257)
16. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Hu FB, Willett WC. Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care 2007; 30: 967-973. (Pubitemid 46556594)
17. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001; 47: 418-425. (Pubitemid 32222454)
18. Huang Y, Cao S, Nagamani M, Anderson KE, Grady JJ, Lu LJ. Decreased circulating levels of tumor necrosis factor-alpha in postmenopausal women during consumption of soy-containing isoflavones. J Clin Endocrinol Metab 2005; 90: 3956-3962. (Pubitemid 41058157)
19. Papadopoulos DP, Perrea D, Thomopoulos C, Sanidas E, Daskalaki M, Papazachou U et al. Masked hypertension and atherogenesis: the impact on adiponectin and resistin plasma levels. J Clin Hypertens 2009; 11: 61-65.
20. Campbell CG, Brown BD, Dufner D, Thorland WG. Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men. Lipids 2006; 41: 257-265.
21. Konig D, Deibert P, Frey I, Landmann U, Berg A. Effect of meal replacement on metabolic risk factors in overweight and obese subjects. Ann Nutr Metab 2008; 52: 74-78. (Pubitemid 351525942)
22. Christie DR, Grant J, Darnell BE, Chapman VR, Gastaldelli A, Sites CK. Metabolic effects of soy supplementation in postmenopausal Caucasian and African American women: a randomized, placebo-controlled trial. Am J Obstet Gynecol 2010; 203: 153.e1-153.e9.
23. Maskarinec G, Steude JS, Franke AA, Cooney RV. Inflammatory markers in a 2-year soy intervention among premenopausal women. J Inflamm 2009; 6: 9.
24. Phipps WR, Wangen KE, Duncan AM, Merz-Demlow BE, Xu X, Kurzer MS. Lack of effect of isoflavonic phytoestrogen intake on leptin concentrations in premenopausal and postmenopausal women. Fertil Steril 2001; 75: 1059-1064. (Pubitemid 32522599)
25. Takahira M, Noda K, Fukushima M, Zhang B, Mitsutake R, Uehara Y et al. Randomized, double-blind, controlled, comparative trial of formula food containing soy protein vs. milk protein in visceral fat obesity. -FLAVO study-. Circ J 2011; 75: 2235-2243.
26. Wu AH, Stanczyk FZ, Martinez C, Tseng CC, Hendrich S, Murphy P et al. A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. Am J Clin Nutr 2005; 81: 1133-1141. (Pubitemid 41724956)
27. King DE. Dietary fiber, inflammation, and cardiovascular disease. Mol Nutr Food Res 2005; 49: 594-600. (Pubitemid 40853705)
28. Finot PA. Proteins and cardiovascular problems. Bibl Nutr Dieta 1992; 49: 83-92.
29. Esposito K, Giugliano D. Diet and inflammation: a link to metabolic and cardiovascular diseases. Eur Heart J 2006; 27: 15-20. (Pubitemid 41785926)
30. Qi L, Hu FB. Dietary glycemic load, whole grains, and systemic inflammation in diabetes: the epidemiological evidence. Curr Opin Lipidol 2007; 18: 3-8. (Pubitemid 46091627)
31. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O et al. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 1999; 18: 4608-4618. (Pubitemid 29415516)
32. Shimizu H, Shimomura Y, Nakanishi Y, Futawatari T, Ohtani K, Sato N et al. Estrogen increases in vivo leptin production in rats and human subjects J Endocrinol 1997; 154: 285-292. (Pubitemid 27330641)
33. Catania MA, Crupi A, Firenzuoli F, Parisi A, Sturiale A, Squadrito F et al. Oral administration of a soy extract improves endothelial dysfunction in ovariectomized rats. Planta Med 2002; 68: 1142-1144. (Pubitemid 36140327)
34. Jiang F, Jones GT, Husband AJ, Dusting GJ. Cardiovascular protective effects of synthetic isoflavone derivatives in apolipoprotein e-deficient mice. J Vasc Res 2003; 40: 276-284. (Pubitemid 36980729)
35. Squadrito F, Altavilla D, Crisafulli A, Saitta A, Cucinotta D, Morabito N et al. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. Am J Med 2003; 114: 470-476. (Pubitemid 36515109)
36. Walker HA, Dean TS, Sanders TA, Jackson G, Ritter JM, Chowienczyk PJ. The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17beta-estradiol. Circulation 2001; 103: 258-262. (Pubitemid 32095412)
37. Beavers DP, Beavers KM, Miller M, Stamey J, Messina MJ. Exposure to isoflavonecontaining soy products and endothelial function: a Bayesian meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 2012; 22: 182-191.
38. Harmon AW, Harp JB. Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am J Physiol Cell Physiol 2001; 280: C807-C813.
39. Park HJ, Della-Fera MA, Hausman DB, Rayalam S, Ambati S, Baile CA. Genistein inhibits differentiation of primary human adipocytes. J Nutr Biochem 2009; 20: 140-148.
40. Zhang M, Ikeda K, Xu JW, Yamori Y, Gao XM, Zhang BL. Genistein suppresses adipogenesis of 3T3-L1 cells via multiple signal pathways. Phytother Res 2009; 23: 713-718.